954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus

• Published in: Journal for ImmunoTherapy of Cancer
• Main Authors: Richard Casey, Wenliang Dong, Tereza Brachtlova, Allan Abramovitch, Jonathan Giddens, Peter Incze, Kenneth Jansz, Victor van Beusechem
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMJ Publishing Group 2021
• Subjects: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282; Orca
• Online Access: https://doi.org/10.1136/jitc-2021-SITC2021.954; https://doaj.org/article/2c4cd2b93c724d0e9682c4265c27a61a